These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12033502)

  • 1. Synthesis and evaluation of 4-bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent.
    Yamamoto F; Aoki M; Furusawa Y; Ando K; Kuwabara Y; Masuda K; Sasaki S; Maeda M
    Biol Pharm Bull; 2002 May; 25(5):616-21. PubMed ID: 12033502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of lipophilic 1-[18F]fluoroalkyl-2-nitroimidazoles for imaging hypoxia.
    Yamamoto F; Oka H; Antoku S; Ichiya Y; Masuda K; Maeda M
    Biol Pharm Bull; 1999 Jun; 22(6):590-7. PubMed ID: 10408232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
    Rasey JS; Hofstrand PD; Chin LK; Tewson TJ
    J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue.
    Jerabek PA; Patrick TB; Kilbourn MR; Dischino DD; Welch MJ
    Int J Rad Appl Instrum A; 1986; 37(7):599-605. PubMed ID: 3021662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors.
    Melo T; Duncan J; Ballinger JR; Rauth AM
    J Nucl Med; 2000 Jan; 41(1):169-76. PubMed ID: 10647620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
    Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
    Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
    Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
    Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of [
    Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
    Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of an
    Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
    Su H; Chu T
    Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO).
    Chang CW; Chou TK; Liu RS; Wang SJ; Lin WJ; Chen CH; Wang HE
    Appl Radiat Isot; 2007 Jun; 65(6):682-6. PubMed ID: 17379530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
    Yang DJ; Wallace S; Cherif A; Li C; Gretzer MB; Kim EE; Podoloff DA
    Radiology; 1995 Mar; 194(3):795-800. PubMed ID: 7862981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
    Ballinger JR; Kee JW; Rauth AM
    J Nucl Med; 1996 Jun; 37(6):1023-31. PubMed ID: 8683295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO).
    Yuan H; Frank JE; Merrill JR; Hillesheim DA; Khachaturian MH; Anzellotti AI
    Curr Radiopharm; 2016; 9(3):235-243. PubMed ID: 27562785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of congeners of misonidazole for imaging hypoxia.
    Grunbaum Z; Freauff SJ; Krohn KA; Wilbur DS; Magee S; Rasey JS
    J Nucl Med; 1987 Jan; 28(1):68-75. PubMed ID: 3794812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β -[
    Kumar P; Roselt P; Reischl G; Cullinane C; Beiki D; Ehrlichmann W; Binns D; Naimi E; Yang J; Hicks R; Machulla HJ; Wiebe LI
    Curr Radiopharm; 2017; 10(2):93-101. PubMed ID: 28294075
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.